Awareness and Knowledge of HIV and H1N1

Drug Development – Lessons learnt from HIV and H1N1:

The humankind is constantly reminded of the threat of newly emerging infectious diseases – the declaration by the World Health Organization (WHO) about the global H1N1 flu pandemic in June 2009 is just one example. By the time Dr. Margaret Chan, Director-General of WHO made the announcement, pandemic level of H1N1 had already reached the highest level (level six) and the numbers of confirmed cases were over 30,000.

The world governments and health agencies need to be prepared for responding to such public health challenges by activating the pandemic plans and doing everything necessary to keep the people safe. Scientific expertise across multiple disciplines needs to be used to combat the threat posed by such emerging infectious diseases.

The term emergent disease includes any disease which is previously unknown; increase in incidence of a previously known disease; disease caused by intentional dissemination of biological products by bioterrorists. Some of the infections that have affected the humankind in the recent past are severe acute respiratory syndrome (SARS), avian influenza (H5N1), antibiotic resistant bacterial infections like methicillin-resistant Staphylococcus aureus (MRSA), and viral hemorrhagic fevers.

Click here to Continue Reading

For more updates visit HarNeedi.com